BSE Live
Jan 14, 13:23Prev. Close
38.54
Open Price
38.42
Bid Price (Qty.)
38.44 (29)
Offer Price (Qty.)
38.47 (463)
NSE Live
Jan 14, 13:23Prev. Close
38.42
Open Price
38.42
Bid Price (Qty.)
38.44 (7540)
Offer Price (Qty.)
38.45 (571)
| Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.04 | -1.03 | -1.36 | -7.47 | -1.62 | |
| Diluted EPS (Rs.) | -0.04 | -1.03 | -1.36 | -7.47 | -1.62 | |
| Cash EPS (Rs.) | 0.98 | 0.24 | -0.05 | -5.14 | 0.71 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 6.68 | 5.46 | 6.49 | 4.17 | 12.09 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 6.68 | 5.46 | 6.49 | 4.17 | 12.09 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 4.35 | 4.59 | 3.53 | 6.09 | 5.48 | |
| PBDIT/Share (Rs.) | 0.30 | 0.08 | -0.16 | -0.57 | 0.60 | |
| PBIT/Share (Rs.) | -0.71 | -1.18 | -1.47 | -2.78 | -1.61 | |
| PBT/Share (Rs.) | -0.78 | -1.24 | -1.73 | -3.03 | -1.64 | |
| Net Profit/Share (Rs.) | -0.04 | -1.03 | -1.36 | -7.47 | -1.62 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 6.92 | 1.72 | -4.53 | -9.38 | 11.03 | |
| PBIT Margin (%) | -16.19 | -25.79 | -41.58 | -45.66 | -29.34 | |
| PBT Margin (%) | -18.01 | -27.02 | -48.94 | -49.76 | -29.87 | |
| Net Profit Margin (%) | -0.88 | -22.45 | -38.70 | -122.59 | -29.54 | |
| Return on Networth / Equity (%) | -0.57 | -18.90 | -21.04 | -179.23 | -13.37 | |
| Return on Capital Employed (%) | -0.31 | -6.18 | -7.57 | -27.05 | -3.11 | |
| Return on Assets (%) | -0.26 | -5.40 | -6.87 | -19.27 | -2.43 | |
| Total Debt/Equity (X) | 0.46 | 1.44 | 1.26 | 5.83 | 3.53 | |
| Asset Turnover Ratio (%) | 30.30 | 24.09 | 17.76 | 15.71 | 8.24 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.66 | 0.69 | 0.64 | 0.45 | 1.47 | |
| Quick Ratio (X) | 0.35 | 0.44 | 0.37 | 0.38 | 1.19 | |
| Inventory Turnover Ratio (X) | 6.43 | 7.68 | 6.92 | 7.48 | 1.38 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 600.41 | 557.31 | 833.31 | 848.00 | 1,005.80 | |
| EV/Net Operating Revenue (X) | 3.07 | 3.40 | 6.61 | 6.60 | 8.70 | |
| EV/EBITDA (X) | 44.26 | 197.13 | -145.80 | -70.31 | 78.89 | |
| MarketCap/Net Operating Revenue (X) | 1.75 | 0.98 | 3.36 | 2.96 | 1.32 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.14 | 0.83 | 1.83 | 4.33 | 0.60 | |
| Price/Net Operating Revenue | 1.75 | 0.98 | 3.36 | 2.96 | 1.32 | |
| Earnings Yield | -0.01 | -0.23 | -0.12 | -0.41 | -0.22 |
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y